Doxepin

Molecular mass: 279.376 g/mol  PubChem compound: 667468

Therapeutic indications

Doxepin is indicated for:

Depression

Population group: only adults (18 years old or older)

Symptoms of depressive illness in adults, especially where sedation is required.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Insomnia

Population group: only adults (18 years old or older)

Doxepin is indicated for the treatment of insomnia characterized by difficulty with sleep maintenance. The clinical trials performed in support of efficacy were up to 3 months in duration.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Doxepin is contraindicated in the following cases:

Lactation

Lactation

Recent myocardial infarction

Myocardial infarction

Mania

Mania

Severe liver disease

Hepatic failure stage IV

Narrow angle glaucoma

Angle-closure glaucoma

Benign prostatic hyperplasia, severe urinary retention

at least one of
Benign prostatic hyperplasia
Retention of urine

Sympathomimetic agents

at least one of
Sympathomimetic amines
Sympathomimetics

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2023: SILENOR Tablet
Summary of Product Characteristics (SPC) 2021: SINEPIN Capsule
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈